LON:SBTX SkinBioTherapeutics (SBTX) Share Price, News & Analysis → FW: 234x Gain (From Weiss Ratings) (Ad) Free SBTX Stock Alerts GBX 9.25 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range 9▼ 9.2550-Day Range 7▼ 12.7552-Week Range 7▼ 29.50Volume59,297 shsAverage Volume641,924 shsMarket Capitalization£18.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get SkinBioTherapeutics alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. About SkinBioTherapeutics Stock (LON:SBTX)SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.Read More SBTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBTX Stock News HeadlinesMay 1, 2024 | ca.finance.yahoo.comSkinBioTherapeutics plc (SBTX.L)March 26, 2024 | finance.yahoo.comSkinBioTherapeutics First Half 2024 Earnings: UK£0.008 loss per share (vs UK£0.008 loss in 1H 2023)May 4, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. March 18, 2024 | lse.co.ukSkinBioTherapeutics announces research into wound healing bacteriumNovember 17, 2023 | uk.investing.comSkinBioTherapeutics bags £3m at a modest discountNovember 16, 2023 | marketwatch.comSkinBioTherapeutics to Raise at Least $3.7 MlnSeptember 14, 2023 | uk.investing.comFiverr International Ltd DRC (F2VR34)September 2, 2023 | uk.investing.comSocietatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)May 4, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. July 11, 2023 | finance.yahoo.comSBTX.L - SkinBioTherapeutics PlcJune 21, 2023 | marketwatch.comSkinBioTherapeutics Gets Approval for Supplement Launch in ItalyMarch 30, 2023 | finance.yahoo.comSkinBioTherapeutics Reports First Half 2023 EarningsMarch 28, 2023 | marketwatch.comSkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher CostsMarch 22, 2023 | finance.yahoo.comIs SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?December 21, 2022 | marketwatch.comSkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail OfferDecember 15, 2022 | marketwatch.comSkinBioTherapeutics to Raise a Minimum of GBP2.5 MlnOctober 14, 2022 | finance.yahoo.comAfter losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gainAugust 31, 2022 | lse.co.ukSkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales dropAugust 31, 2022 | marketwatch.comSkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement SalesJune 15, 2022 | proactiveinvestors.comSkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatmentJune 13, 2022 | marketwatch.comSkinBioTherapeutics Knows No Reason For Share Price FallMay 20, 2022 | news.yahoo.comWhat It's Like Inside a Burning Drift CarMay 20, 2022 | news.yahoo.comReport raises concerns over lay-offs, cash flow at Cottage clinic; records issues resolvedMay 18, 2022 | finance.yahoo.comWe're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn RateMarch 29, 2022 | lse.co.ukSkinBioTherapeutics proposes Manprit Singh Randhawa as new CFOMarch 29, 2022 | marketwatch.comSkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax LossFebruary 17, 2022 | finance.yahoo.comWhat Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?See More Headlines Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/03/2020Today5/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SBTX CUSIPN/A CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,880,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-118.63% Return on Assets-61.18% Debt Debt-to-Equity Ratio2.66 Current Ratio6.57 Quick Ratio10.01 Sales & Book Value Annual Sales£21,949.00 Price / Sales844.46 Cash FlowGBX 1.03 per share Price / Cash Flow9.00 Book ValueGBX 2 per share Price / Book4.63Miscellaneous Outstanding Shares200,380,000Free FloatN/AMarket Cap£18.54 million OptionableNot Optionable Beta1.61 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Stuart John Ashman (Age 58)CEO & Executive Director Comp: $371.1kMr. Manprit Singh Randhawa (Age 41)CFO, Secretary & Director Comp: $261.48kLaura BeyHead of FormulationsMs. Melissa GreenwellGroup Financial ControllerKey CompetitorsOptiBiotix HealthLON:OPTIDestiny PharmaLON:DESTSareumLON:SARAorTech InternationalLON:AOROxford BioDynamicsLON:OBDView All Competitors SBTX Stock Analysis - Frequently Asked Questions How have SBTX shares performed in 2024? SkinBioTherapeutics' stock was trading at GBX 15.25 at the start of the year. Since then, SBTX shares have decreased by 39.3% and is now trading at GBX 9.25. View the best growth stocks for 2024 here. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics plc (LON:SBTX) posted its quarterly earnings results on Tuesday, March, 3rd. The company reported ($0.64) EPS for the quarter. What other stocks do shareholders of SkinBioTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX). How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SBTX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
